share_log

Ultragenyx Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Fust Matthew K

SEC announcement ·  Mar 11 12:57
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more